Verily, a subsidiary of Alphabet, recently introduced its newly developed Verily Study Watch. This wearable was made more for the clinical research rather than the consumer and offers continuous monitoring, making collecting data as easy as ever.
According to a Verily blog describing the wearable, this device will be capable of measuring data on “electrocardiogram (ECG), heart rate, electrodermal activity and inertial movements” by targeting “cardiovascular, movement disorders and other areas.”
Verily hopes the wearable will be used in the continuous collection of data in real-time, allowing for improved research.
Read the full story by clicking the link below: